Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial ; volume:14 ; number:1 ; day:2 ; month:9 ; year:2023 ; pages:1-14 ; date:12.2023
Nature Communications ; 14, Heft 1 (2.9.2023), 1-14, 12.2023

Creator: Monjazeb, Arta M.
Daly, Megan E.
Luxardi, Guillaume
Maverakis, Emanual
Merleev, Alexander A.
Marusina, Alina I.
Borowsky, Alexander
Mirhadi, Amin
Shiao, Stephen L.
Beckett, Laurel
Chen, Shuai
Eastham, David
Li, Tianhong
Vick, Logan V.
McGee, Heather M.
Lara, Frances
Garcia, Leslie
Morris, Leigh Anne
Canter, Robert J.
Riess, Jonathan W.
Schalper, Kurt A.
Murphy, William J.
Kelly, Karen

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-023-40813-w

URN: urn:nbn:de:101:1-2024013111495943157498

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 16.09.20252025, 3:26 PM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Monjazeb, Arta M.
Daly, Megan E.
Luxardi, Guillaume
Maverakis, Emanual
Merleev, Alexander A.
Marusina, Alina I.
Borowsky, Alexander
Mirhadi, Amin
Shiao, Stephen L.
Beckett, Laurel
Chen, Shuai
Eastham, David
Li, Tianhong
Vick, Logan V.
McGee, Heather M.
Lara, Frances
Garcia, Leslie
Morris, Leigh Anne
Canter, Robert J.
Riess, Jonathan W.
Schalper, Kurt A.
Murphy, William J.
Kelly, Karen
SpringerLink (Online service)

Other Objects (12)

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

Abschnitt

Ablativ

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"

$Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer$

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Kapitel

Zehntes Capitel. Vom Ablativ

Kapitel

B. Inoperable Fälle.

Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

Abschnitt

Ablativ

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"

$Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer$

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Kapitel

Zehntes Capitel. Vom Ablativ

Kapitel

B. Inoperable Fälle.

Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

Abschnitt

Ablativ

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"

$Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer$

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Kapitel

Zehntes Capitel. Vom Ablativ

Kapitel

B. Inoperable Fälle.

Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

Ablativ

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Zehntes Capitel. Vom Ablativ

B. Inoperable Fälle.

Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

Ablativ

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Zehntes Capitel. Vom Ablativ

B. Inoperable Fälle.

Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

Ablativ

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Zehntes Capitel. Vom Ablativ

B. Inoperable Fälle.

Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer

Related objects

Reset password